Shuli Li

11.9k total citations · 1 hit paper
239 papers, 6.9k citations indexed

About

Shuli Li is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Shuli Li has authored 239 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 50 papers in Cell Biology and 44 papers in Oncology. Recurrent topics in Shuli Li's work include melanin and skin pigmentation (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Head and Neck Cancer Studies (19 papers). Shuli Li is often cited by papers focused on melanin and skin pigmentation (47 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Head and Neck Cancer Studies (19 papers). Shuli Li collaborates with scholars based in United States, China and Italy. Shuli Li's co-authors include Chunying Li, Michael T. Longaker, Natalina Quarto, Tianwen Gao, Jianru Chen, Robert J. Soiffer, Yinghan Wang, Zhe Jian, Xiuli Yi and Benjamin Lévi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shuli Li

226 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shuli Li	2.1k	1.3k	1.2k	1.2k	1.0k	239	6.9k
Charles C. Hong	3.6k 1.7×	639 0.5×	550 0.5×	540 0.5×	1.2k 1.1×	141	6.9k
Qingyu Wu	2.3k 1.1×	423 0.3×	1.0k 0.8×	1.0k 0.9×	567 0.6×	233	7.7k
Bing Liu	1.9k 0.9×	551 0.4×	1.3k 1.1×	1.3k 1.1×	550 0.5×	224	5.1k
Hiroaki Kataoka	4.0k 1.9×	529 0.4×	1.9k 1.5×	1.1k 0.9×	1.3k 1.2×	295	8.1k
Steven Dooley	4.5k 2.1×	849 0.7×	1.7k 1.4×	1.1k 0.9×	1.6k 1.6×	237	10.2k
Paul J. Higgins	4.0k 1.9×	797 0.6×	1.2k 1.0×	1.1k 0.9×	835 0.8×	226	8.5k
Clemens D. Cohen	3.7k 1.8×	541 0.4×	1.3k 1.0×	2.1k 1.7×	1.1k 1.1×	146	9.8k
Stuart J. Shankland	6.8k 3.2×	667 0.5×	1.3k 1.1×	1.8k 1.6×	1.5k 1.5×	229	15.2k
Akira Ooshima	3.9k 1.9×	697 0.5×	942 0.8×	781 0.7×	1.3k 1.3×	240	9.5k
Taketo Yamada	2.1k 1.0×	336 0.3×	1.2k 1.0×	2.7k 2.3×	1.7k 1.6×	177	7.5k

Countries citing papers authored by Shuli Li

Since Specialization

Citations

This map shows the geographic impact of Shuli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Li more than expected).

Fields of papers citing papers by Shuli Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Li. The network helps show where Shuli Li may publish in the future.

Co-authorship network of co-authors of Shuli Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuli Li. A scholar is included among the top collaborators of Shuli Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuli Li. Shuli Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Wei, et al.. (2024). From mice to men: An assessment of preclinical model systems for the study of vitiligo. Clinical Immunology. 262. 110171–110171. 2 indexed citations

Gong, Xiaoqing, Shuli Li, Junli Huang, et al.. (2024). Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation. European Journal of Medicinal Chemistry. 279. 116812–116812. 5 indexed citations

Sun, Weiwei, et al.. (2024). Changes in epidermal thickness and their correlation with clinical characteristics in patients with vitiligo. Archives of Dermatological Research. 316(8). 519–519. 1 indexed citations

Chen, Jianru, et al.. (2024). Circulating memory T cells and TCF1+ T cells aid in diagnosis and monitor disease activity in vitiligo. Journal of Pharmaceutical Analysis. 14(11). 100998–100998. 2 indexed citations

Kang, Pan, Yinghan Wang, Jianru Chen, et al.. (2024). TRPM2 ‐dependent autophagy inhibition exacerbates oxidative stress‐induced CXCL16 secretion by keratinocytes in vitiligo. The Journal of Pathology. 262(4). 441–453. 9 indexed citations

Chang, Yuqian, Pan Kang, Tingting Cui, et al.. (2023). Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo. Journal of Translational Medicine. 21(1). 434–434. 19 indexed citations

Zhu, Guannan, Pan Kang, Jianru Chen, et al.. (2023). Influences of vitiligo‐associated characteristics on the occurrence of diabetes mellitus: Interactive analysis of a cross‐sectional study. Experimental Dermatology. 32(10). 1805–1814. 4 indexed citations

Patel, Nicole, Johanna Nunez, Michael Sorkin, et al.. (2022). Macrophage TGF-β signaling is critical for wound healing with heterotopic ossification after trauma. JCI Insight. 7(20). 25 indexed citations

Yi, Xiuli, Shaolong Zhang, Shuli Li, et al.. (2021). RIP1-Mediated Necroptosis Facilitates Oxidative Stress‒Induced Melanocyte Death, Offering Insight into Vitiligo. Journal of Investigative Dermatology. 141(12). 2921–2931.e6. 13 indexed citations

10.

Zhang, Shaolong, Shuli Li, Yuqi Yang, et al.. (2021). Folic Acid Protects Melanocytes from Oxidative Stress via Activation of Nrf2 and Inhibition of HMGB1. Oxidative Medicine and Cellular Longevity. 2021(1). 1608586–1608586. 17 indexed citations

11.

Cui, Tingting, Yinghan Wang, Pu Song, et al.. (2021). HSF1-Dependent Autophagy Activation Contributes to the Survival of Melanocytes Under Oxidative Stress in Vitiligo. Journal of Investigative Dermatology. 142(6). 1659–1669.e4. 21 indexed citations

12.

Chen, Jiaxi, Jianru Chen, Yangzi Tian, et al.. (2020). Homocysteine induces melanocytes apoptosis via PERK–eIF2α–CHOP pathway in vitiligo. Clinical Science. 134(10). 1127–1141. 17 indexed citations

13.

Johnson, Douglas B., Fengmin Zhao, Marcus Smith Noel, et al.. (2020). Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). Clinical Cancer Research. 26(8). 1812–1819. 42 indexed citations

14.

Chen, Jianru, Shuli Li, & Chunying Li. (2020). Mechanisms of melanocyte death in vitiligo. Medicinal Research Reviews. 41(2). 1138–1166. 180 indexed citations

15.

Chen, Yi‐Bin, Nahel Elias, Eliot Heher, et al.. (2019). Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure. Blood. 134(2). 211–215. 19 indexed citations

16.

Marur, Shanthi, Shuli Li, Anthony J. Cmelak, et al.. (2017). E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 35(5). 490–497. 317 indexed citations breakdown →

17.

Agarwal, Shailesh, Shawn Loder, Cameron Brownley, et al.. (2015). Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification. Proceedings of the National Academy of Sciences. 113(3). E338–47. 172 indexed citations

18.

Quarto, Natalina, Brian C. Leonard, Shuli Li, et al.. (2011). Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells. Proceedings of the National Academy of Sciences. 109(1). 215–220. 59 indexed citations

19.

Winter, Jane N., Shuli Li, Daina Variakojis, et al.. (2010). Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494. Clinical Cancer Research. 16(8). 2435–2442. 26 indexed citations

20.

Volchenboum, Samuel L., Cheng Li, Shuli Li, et al.. (2009). Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis. Cancer Research. 69(10). 4143–4149. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact